Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory metabolic, oncologic and autoimmune diseases

摘要

Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.